M&G
M&G plc is a prominent savings and investments firm established in 2017 through the merger of Prudential plc’s UK and Europe savings and insurance operations with M&G, its international investment manager. Following its demerger from Prudential plc, M&G plc operates under two key brands: Prudential, serving savings and insurance customers in the UK and Europe, and M&G Investments, which caters to asset management clients globally. The firm manages a diverse range of investment products across various asset classes, including equities, multi-asset, fixed income, real estate, and cash, serving both retail and institutional clients in 28 markets. M&G manages significant private assets, including bank loans, infrastructure, and real estate, while also providing financial planning services through a network of advisers in the UK. With a commitment to delivering tailored investment solutions, M&G plc plays a vital role in helping customers navigate their financial futures.
Top Stages
https://crunchbase.com/organization/***
https://linkedin.com/company/***
13 past transactions
Udaan
Series G in 2025
Udaan is a B2B e-commerce platform based in India that connects businesses with suppliers across various sectors, including FMCG, pharmaceuticals, and staples. It aims to address core trade challenges faced by small, medium, and large enterprises by providing a centralized platform for buying and selling goods. Udaan facilitates direct connections between clients, allowing them to negotiate better deals while ensuring secure payment processes and efficient logistics. The platform also supports small businesses by offering financial products tailored to their needs, thereby enhancing their operational capabilities and market reach.
SeQura
Venture Round in 2024
SeQura provides an eCommerce payment solution for retailers that improves conversion and secures certainty of payment. The company offers a range of payment methods, including Pay Now, Buy Now Pay Later, and Pay in 3. Founded in 2013 and headquartered in Barcelona, Spain, SeQura delivers flexible and accessible credit payment services across diverse sectors to boost customer acquisition, conversion, and retention. It uses risk scoring to extend credit access to underserved shoppers and provides tailored services for different industries, including options such as interest-free credit and installments, enabling businesses to optimize sales and appeal to value-conscious shoppers with convenient payment experiences.
BauMont
Acquisition in 2024
BauMont is a real estate private equity investment firm that offers investment management services.
Nuclera
Series C in 2024
Nuclera specializes in accelerating drug discovery by providing a protein prototyping system. Its eProtein Discovery™ platform enables scientists to rapidly produce and test proteins for research purposes.
Apollo Therapeutics
Series C in 2024
Apollo Therapeutics is a collaborative biopharmaceutical venture bridging three UK universities—Imperial College London, University College London, and the University of Cambridge—and three global pharmaceutical companies—AstraZeneca, GlaxoSmithKline, and Johnson & Johnson Innovation. It provides translational funding and drug discovery expertise to translate fundamental academic research into medicines, supporting preclinical and clinical development. The company builds an expansive, de-risked portfolio across oncology, major inflammatory disorders, and rare diseases, focusing on assets with strong biological hypotheses. Its team of industry scientists works with academics and industry partners to tailor projects, aiming to accelerate the path from discovery to the clinic and improve patient outcomes. By leveraging the UK science base and domestic pharma capabilities, Apollo Therapeutics seeks to deliver new therapies that address significant medical needs.
Udaan
Series E in 2023
Udaan is a B2B e-commerce platform based in India that connects businesses with suppliers across various sectors, including FMCG, pharmaceuticals, and staples. It aims to address core trade challenges faced by small, medium, and large enterprises by providing a centralized platform for buying and selling goods. Udaan facilitates direct connections between clients, allowing them to negotiate better deals while ensuring secure payment processes and efficient logistics. The platform also supports small businesses by offering financial products tailored to their needs, thereby enhancing their operational capabilities and market reach.
Apollo Therapeutics
Series C in 2023
Apollo Therapeutics is a collaborative biopharmaceutical venture bridging three UK universities—Imperial College London, University College London, and the University of Cambridge—and three global pharmaceutical companies—AstraZeneca, GlaxoSmithKline, and Johnson & Johnson Innovation. It provides translational funding and drug discovery expertise to translate fundamental academic research into medicines, supporting preclinical and clinical development. The company builds an expansive, de-risked portfolio across oncology, major inflammatory disorders, and rare diseases, focusing on assets with strong biological hypotheses. Its team of industry scientists works with academics and industry partners to tailor projects, aiming to accelerate the path from discovery to the clinic and improve patient outcomes. By leveraging the UK science base and domestic pharma capabilities, Apollo Therapeutics seeks to deliver new therapies that address significant medical needs.
Bluejay Mining
Post in 2023
Bluejay Mining engages in the exploration and development of precious and base metals across the United Kingdom, Greenland, and Finland. Its primary focus is the Dundas ilmenite project in Greenland, which is one of the world's highest-grade mineral sand ilmenite projects.
Teylor
Debt Financing in 2023
Founded in 2018, Teylor specializes in streamlining business loans for SMEs. Headquartered in Zurich with a presence in Konstanz, Germany, the company offers loans of up to €250,000 within two days via its user-friendly online platform. Teylor partners with various financial institutions to license its automated underwriting processes, reducing costs and bureaucracy.
eTherapeutics
Post in 2022
eTherapeutics is a drug discovery and development company based in the UK. It focuses on transforming the drug discovery process by utilizing its proprietary computational network biology platform. This advanced system enables the swift and accurate analysis of drug interactions with cells, aiming to identify novel targets that address the mechanisms underlying complex diseases. By optimizing the identification of drug candidates with desirable efficacy and minimal side effects, eTherapeutics seeks to enhance the drug development process and contribute to the advancement of medical treatments.
Finance Ireland
Secondary Market in 2022
Finance Ireland is a non-bank lender that focuses on providing a variety of financing solutions across several sectors, including agriculture, construction, healthcare, dental, and retail. As Ireland's largest independent motor finance company, it facilitates the purchase of vehicles for over 25,000 car buyers annually. In addition to motor finance, Finance Ireland offers comprehensive lending options for small and medium enterprises (SMEs) and the agricultural sector, covering investments in vehicles, machinery, plants, and equipment. The company aims to provide an alternative to traditional banking, offering both residential and commercial mortgages as part of its diverse financial services. With a dedicated team of lending managers, Finance Ireland assists investors throughout the funding process.
Ascentric
Acquisition in 2020
Ascentric is a digital wrap and wealth management platform for advisers with assets under administration.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.